0

During the recent Midyear Meeting in Orlando, IPhO and its National Fellows Council hosted an exciting event for Fellows of all Fellowship Programs to network and to learn more about how to get a full time position post-fellowship. Moderated by IPhO Executive Director Jim Alexander, the program featured a series of roundtable discussions with successful fellowship alumni/industry executives who shared their insights and guidance on how to pursue a full-time position within industry.

IPhO ASHP Midyear 2017-1 IPhO ASHP Midyear 2017-11 IPhO ASHP Midyear 2017-14

(photos courtesy of Andy Szeto)

The IPhO National Fellows Council would like to thank the following table discussion leaders for volunteering their time and sharing their key insights:

  • Adrienne Aiello, Associate Director, Scientific Publications and Communications, Sanofi Genzyme
  • Keelin Dahl, Associate Medical Affairs Director, Biosimilars, Merck
  • Rob Farina, Executive Director, Field Medical Health Systems, Merck
  • Sergio Gatoulis, Director, Global Clinical Research, Pfizer Consumer
  • Aansh Jarmarwala, Senior Associate, Global Regulatory Strategy, Takeda
  • Ahmad Khan, MSL, Multiple Sclerosis, Sanofi Genzyme
  • Elvis Osei Tutu, Manager, Global Regulatory Affairs, GlaxoSmithKline
  • Lucie Vu, Senior Manager, Medical Communications & Publications, Cytokinetics
  • Alex Wei, MSL, Medical Affairs, Alnylam

IPhO would like to thank Sanofi Genzyme for its generous support of this event!

Sanofi+Genzyme+-+RGB+-+Colors

Stay tuned for more IPhO networking events in the near future!

About the Author
James Alexander, PharmD
Dr. Alexander is a strong advocate for the role that pharmacists can play in the pharmaceutical industry. In his new role as Founder and Executive Director of IPhO, the first professional organization designed exclusively for industry-based pharmacists, Jim brings his distinguished experience in advocacy and professional development to support the professional careers of the growing number of industry-based pharmacists.

If you'd like to comment, please create an account, or login:

Become a Member
Login to your account